Advertisement

Pilonidal Disease and Hidradenitis Suppurativa

  • Eric K. JohnsonEmail author
Chapter

Abstract

Pilonidal disease and hidradenitis suppurativa are both chronic inflammatory diseases that affect patients in the prime of their lives. They can significantly impact an individual’s quality of life and may cause significant disability and consumption of health care. Both diseases may be approached non-operatively, but in many or most, surgery will ultimately be required. This chapter outlines several approaches to both the simple and complex patient, and also provides background and medical options as they relate to these processes. It is imperative to tailor the treatment approach to disease severity, anatomy, and the patient’s expectations.

Keywords

Pilonidal disease Hidradenitis suppurativa Cleft lift Limberg flap Rhomboid flap Karydakis flap 

Supplementary material

Video 17.1

Video of a Bascom cleft lift procedure for pilonidal disease (MPG 61380 kb)

Video 17.2

Video of a rhomboid flap for pilonidal disease (MOV 94672 kb)

References

  1. 1.
    Hodges RM. Pilonidal sinus. Boston Med Surg J. 1880;103:485–6.Google Scholar
  2. 2.
    Anderson AW. Hair extracted from an ulcer. Boston Med Surg J. 1847;36:74.Google Scholar
  3. 3.
    Warren JM. Abscess, containing hair, on the nates. Am J Med Sci. 1854;28:113.Google Scholar
  4. 4.
    Buie LA. Jeep disease (pilonidal disease of mechanized warfare). South Med J. 1944;37:103–9.Google Scholar
  5. 5.
    Close AS. Pilonidal cysts: an analysis of surgical failures. Ann Surg. 1955;141:523–6.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Von Laffert M, Stadie V, Ulrich J, Marsch WC, Wohlrab J. Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa. Dermatology. 2011;223:349–55.Google Scholar
  7. 7.
    Uysal AC, Alagoz MS, Unlu RE, Sensoz O. Hair dresser’s syndrome: a case report of an interdigital pilonidal sinus and review of the literature. Dermatol Surg. 2003;29:288–90.PubMedGoogle Scholar
  8. 8.
    Coskun A, Bulus H, Akinci OF, Ozgonul A. Etiological factors in umbilical pilonidal sinus. Indian J Surg. 2011;73:54–7.PubMedGoogle Scholar
  9. 9.
    Armed Forces Health Surveillance Center (AFHSC). Pilonidal cysts, active component, U.S. Armed Forces, 2000–2012. MSMR. 2013;20:8–11.Google Scholar
  10. 10.
    Bolandparvaz S, Moghadam DP, Salahi R, Paydar S, Bananzadeh M, Abbasi HR, Eshraghian A. Evaluation of the risk factors of pilonidal sinus: a single center experience. Turk J Gastroenterol. 2012;23:535–7.PubMedGoogle Scholar
  11. 11.
    Doll D, Matevossian E, Wietelmann K, Evers T, Kriner M, Petersen S. Family history of pilonidal sinus predisposes to earlier onset of disease and a 50% long-term recurrence rate. Dis Colon Rectum. 2009;52:1610–5.PubMedGoogle Scholar
  12. 12.
    Harlak A, Mentes O, Kilic S, Coskun K, Duman K, Yilmaz F. Sacrococcygeal pilonidal disease: analysis of previously proposed risk factors. Clinics. 2010;65:125–31.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Armstrong JH, Barcia PJ. Pilonidal sinus disease. The conservative approach. Arch Surg. 1994;129:914–7.PubMedGoogle Scholar
  14. 14.
    Odili J, Gault D. Laser depilation of the natal cleft—an aid to healing the pilonidal sinus. Ann R Coll Surg Engl. 2002;84:29–32.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Landa N, Aller O, Landa-Gundin N, Torrontegui J, Azpiazu JL. Successful treatment of recurrent pilonidal sinus with laser epilation. Dermatol Surg. 2005;31:726–8.PubMedGoogle Scholar
  16. 16.
    Lukish JR, Kindelan T, Marmon LM, Pennington M, Norwood C. Laser epilation is safe and effective therapy for teenagers with pilonidal disease. J Pediatr Surg. 2009;44:282–5.PubMedGoogle Scholar
  17. 17.
    Ghnnam WM, Hafez DM. Laser hair removal as adjunct to surgery for pilonidal sinus: our initial experience. J Cutan Aesthet Surg. 2011;4:192–5.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Petersen S, Wietelmann K, Evers T, Huser N, Matevossian E, Doll D. Long-term effects of postoperative razor epilation in pilonidal sinus disease. Dis Colon Rectum. 2009;52:131–4.PubMedGoogle Scholar
  19. 19.
    Schneider IH, Thaler K, Kockerling F. Treatment of pilonidal sinus by phenol injections. Int J Colorectal Dis. 1994;9:200–2.PubMedGoogle Scholar
  20. 20.
    Dogru O, Camci C, Aygen E, Girgin M, Topuz O. Pilonidal sinus treated with crystallized phenol: an eight-year experience. Dis Colon Rectum. 2004;47:1934–8.PubMedGoogle Scholar
  21. 21.
    Hegge HG, Vos GA, Patka P, Hoitsma HF. Treatment of complicated or infected pilonidal sinus disease by local application of phenol. Surgery. 1987;102:52–4.PubMedGoogle Scholar
  22. 22.
    Stansby G, Greatorex R. Phenol treatment of pilonidal sinuses of the natal cleft. Br J Surg. 1989;729–30.PubMedGoogle Scholar
  23. 23.
    Lund JN, Leveson SH. Fibrin glue treatment of pilonidal sinus: results of a pilot study. Dis Colon Rectum. 2005;48:1094–6.PubMedGoogle Scholar
  24. 24.
    Seleem MI, Al-Hashemy AM. Management of pilonidal sinus using fibrin glue: a new concept and preliminary experience. Colorectal Dis. 2005;7:319–22.PubMedGoogle Scholar
  25. 25.
    Greenberg R, Kashtan H, Skornik Y, Werbin N. Treatment of pilonidal sinus disease using fibrin glue as a sealant. Tech Coloproctol. 2004;8:95–8.PubMedGoogle Scholar
  26. 26.
    Elsey E, Lund JN. Fibrin glue in the treatment for pilonidal sinus: high patient satisfaction and rapid return to normal activities. Tech Coloproctol. 2013;17:101–4.PubMedGoogle Scholar
  27. 27.
    Milone M, Musella M, Di Sardo Spiezio A, Bifulco G, Salvatore G, Sosa Fernandez LM, Bianco P, Zizolfi B, Nappi C, Milone F. Video-assisted ablation of pilonidal sinus: a new minimally invasive treatment—a pilot study. Surgery. 2014;155:562–6.PubMedGoogle Scholar
  28. 28.
    Alptekin H, Yilmaz H, Kayis SA, Sahin M. Volume of excised specimen and prediction of surgical site infection in pilonidal sinus procedures (surgical site infection after pilonidal sinus surgery). Surg Today. 2013;43:1365–70.PubMedGoogle Scholar
  29. 29.
    Milone M, Musella M, Salvatore G, Leongito M, Milone F. Effectiveness of a drain in surgical treatment of sacrococcygeal pilonidal disease. Results of a randomized and controlled clinical trial on 803 consecutive patients. Int J Colorectal Dis. 2011;26:1601–7.PubMedGoogle Scholar
  30. 30.
    Milone M, Di Minno MN, Musella M, Maietta P, Ambrosino P, Pisapia A, Salvatore G, Milone F. The role of drainage after excision and primary closure of pilonidal sinus: a meta-analysis. Tech Coloproctol. 2013;17:625–30.PubMedGoogle Scholar
  31. 31.
    Lorant T, Ribbe I, Mahteme H, Gustafsson UM, Graf W. Sinus excision and primary closure versus laying open in pilonidal disease: a prospective randomized trial. Dis Colon Rectum. 2011;54:300–5.PubMedGoogle Scholar
  32. 32.
    Rao MM, Zawislak W, Kennedy R, Gilliland R. A prospective randomized study comparing two treatment modalities for chronic pilonidal sinus with a 5-year follow-up. Int J Colorectal Dis. 2010;25:395–400.PubMedGoogle Scholar
  33. 33.
    Aldagal SM, Kensarah AA, Alhabboubi M, Ashy AA. A new technique in management of pilonidal sinus, a university teaching hospital experience. Int Surg. 2013;98:304–6.Google Scholar
  34. 34.
    Doll D, Novotny A, Rothe R, Kristiansen JE, Wietelmann K, Boulesteix AL, Dusel W, Petersen S. Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease. Int J Colorectal Dis. 2008;23:181–7.PubMedGoogle Scholar
  35. 35.
    Colv EP, Bertelsen CA. Short convalescence and minimal pain after out-patient Bascom’s pit pick operation. Dan Med Bull. 2011;58:A4348.Google Scholar
  36. 36.
    Olmez A, Kayaalp C, Aydin C. Treatment of pilonidal disease by combination of pit excision and phenol application. Tech Coloproctol. 2013;17:201–6.PubMedGoogle Scholar
  37. 37.
    Can MF, Sevinc MM, Yilmaz M. Comparison of Karydakis flap reconstruction versus primary midline closure in sacrococcygeal pilonidal disease: results of 200 military service members. Surg Today. 2009;39:580–6.PubMedGoogle Scholar
  38. 38.
    Can MF, Sevinc MM, Hancerliogullari O, Yilmaz M, Yagci G. Multicenter prospective randomized trial comparing modified Limberg flap transposition and Karydakis flap reconstruction in patients with sacrococcygeal pilonidal disease. Am J Surg. 2010;200:318–27.PubMedGoogle Scholar
  39. 39.
    Bessa SS. Comparison of short-term results between the modified Karydakis flap and the modified Limberg flap in the management of pilonidal sinus disease: a randomized controlled study. Dis Colon Rectum. 2013;56:491–8.PubMedGoogle Scholar
  40. 40.
    Gendy AS, Glick RD, Hong AR, Dolgin SE, Soffer SZ, Landers H, Herrforth M, Rosen NG. A comparison of the cleft lift procedure vs wide excision and packing for the treatment of pilonidal disease in adolescents. J Pediatr Surg. 2011;46:1256–9.PubMedGoogle Scholar
  41. 41.
    Dudink R, Veldkamp J, Nienhuijs S, Heemskerk J. Secondary healing versus midline closure and modified Bascom natal cleft lift for pilonidal sinus disease. Scand J Surg. 2011;100:110–3.PubMedGoogle Scholar
  42. 42.
    Guner A, Boz A, Ozkan OF, Ileli O, Kece C, Reis E. Limberg flap versus Bascom cleft lift techniques for sacrococcygeal pilonidal sinus: prospective, randomized trial. World J Surg. 2013;37:2074–80.PubMedGoogle Scholar
  43. 43.
    Altintoprak F, Gundogdu K, Ergonenc T, Dikicier E, Cakmak G, Celebi F. Retrospective review of pilonidal sinus patients with early discharge after limberg flap procedure. Int Surg. 2014;99:28–34.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Kaya B, Eris C, Atalay S, Bat O, Bulut NE, Mantoglu B, Karabulut K. Modified Limberg transposition flap in the treatment of pilonidal sinus disease. Tech Coloproctol. 2012;16:55–9.PubMedGoogle Scholar
  45. 45.
    Osmanoglu G, Yetisir F. Limberg flap is better for the surgical treatment of pilonidal sinus. Results of a 767 patients series with an at least five years follow-up period. Chirurgia (Bucur). 2011;106:491–4.Google Scholar
  46. 46.
    Horwood J, Hanratty D, Chandran P, Billings P. Primary closure or rhomboid excision and Limberg flap for the management of primary sacrococcygeal pilonidal disease? A meta-analysis of randomized controlled trials. Colorectal Dis. 2012;14:143–51.PubMedGoogle Scholar
  47. 47.
    Khan PS, Hayat H, Hayat G. Limberg flap versus primary closure in the treatment of primary sacrococcygeal pilonidal disease; a randomized clinical trial. Indian J Surg. 2013;75:192–4.PubMedGoogle Scholar
  48. 48.
    Dass TA, Zaz M, Rather A, Bari S. Elliptical excision with midline primary closure versus rhomboid excision with limberg flap reconstruction in sacrococcygeal pilonidal disease: a prospective, randomized study. Indian J Surg. 2012;74:305–8.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Sit M, Aktas G, Yilmaz EE. Comparison of the three surgical flap techniques in pilonidal sinus surgery. Am Surg. 2013;79:1263–8.PubMedGoogle Scholar
  50. 50.
    Arslan K, Said Kokcam S, Koksal H, Turan E, Atay A, Dogru O. Which flap should be preferred for the treatment of pilonidal sinus? A prospective randomized study. Tech Coloproctol. 2014;18:29–37.PubMedGoogle Scholar
  51. 51.
    Saylam B, Balli DN, Duzgun AP, Ozer MV, Coskun F. Which surgical procedure offers the best treatment for pilonidal disease? Langenbecks Arch Surg. 2011;396:651–8.PubMedGoogle Scholar
  52. 52.
    Onder A, Girgin S, Kapan M, Toker M, Arikanoglu Z, Palanci Y, Bac B. Pilonidal sinus disease: risk factors for postoperative complications and recurrence. Int Surg. 2012;97:224–9.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Sievert H, Evers T, Matevossian E, Hoenemann C, Hoffman S, Doll D. The influence of lifestyle (smoking and body mass index) on wound healing and long-term recurrence rate in 534 primary pilonidal sinus patients. Int J Colorectal Dis. 2013;28:1555–62.PubMedGoogle Scholar
  54. 54.
    Doll D, Matevossian E, Hoenemann C, Hoffman S. Incision and drainage preceding definitive surgery achieves lower 20-year long-term recurrence rate in 583 primary pilonidal sinus surgery patients. J Dtsch Dermatol Ges. 2013;11:60–4.PubMedGoogle Scholar
  55. 55.
    Doll D, Evers T, Krapohl B, Matevossian E. Is there a difference in outcome (long-term recurrence rate) between emergency and elective pilonidal sinus surgery? Minerva Chir. 2013;68:199–205.PubMedGoogle Scholar
  56. 56.
    Doll D, Krueger CM, Schrank S, Dettmann H, Petersen S, Duesel W. Timeline of recurrence after primary and secondary pilonidal sinus surgery. Dis Colon Rectum. 2007;50:1928–34.PubMedGoogle Scholar
  57. 57.
    Verneuil A. De l’hidrosadenite phlegmoneuse et des asbces sudoripares. Arch Gen Med. 1864;2:537–57.Google Scholar
  58. 58.
    Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa. A Canadian study. Am J Clin Dermatol. 2015;16:61–5.Google Scholar
  59. 59.
    Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29:371–6.Google Scholar
  60. 60.
    Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015. doi: 10.1111/jdv.12966. [Epub ahead of print].PubMedGoogle Scholar
  61. 61.
    Shahi V, Alikhan A, Vazquez BG, Weaver AL, Davis MD. Prevalence of hidradenitis suppurativa: a population-based study in Olmstead County, Minnesota. Dermatology. 2014;229:154–8.PubMedPubMedCentralGoogle Scholar
  62. 62.
    McMillan K. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States. Am J Epidemiol. 2014;179:1477–83.PubMedGoogle Scholar
  63. 63.
    Deckers IE, van der Zee HH, Boer J, Prens EP. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol. 2015;Pii:S0190-9622(14)02202-6. doi: 10.1016/j.jaad.2014.11.017.CrossRefGoogle Scholar
  64. 64.
    Kirby JS, Miller JJ, Adams DR, Leslie D. Health care utilization patterns and costs for patients with hidradenitis suppurativa. JAMA Dermatol. 2014;150:937–44.PubMedGoogle Scholar
  65. 65.
    Micheletti RG. Hidadenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology. Semin Cutan Med Surg. 2014;33(3 suppl):S48–50.PubMedGoogle Scholar
  66. 66.
    Gill L, Williams M, Hamzavi I. Update on hidradenitis suppurativa: connecting the tracts. F1000Prime Rep. 2014;6:112.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Asgeirsson T, Nunoo R, Luchtefeld MA. Hidradenitis suppurativa and pruritus ani. Clin Colon Rectal Surg. 2011;24:71–80.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Danby FW, Jemec GB, Marsch WC, von Laffert M. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol. 2013;168:1034–9.PubMedGoogle Scholar
  69. 69.
    Micheletti RG. Natural history, presentation, and diagnosis of hidradenitis suppurativa. Semin Cutan Med Surg. 2014;33(3 suppl):S51–3.PubMedGoogle Scholar
  70. 70.
    Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014;171:819–24.PubMedGoogle Scholar
  71. 71.
    Thomas CL, Gordon KD, Mortimer PS. Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol. 2014;39:315–7.PubMedGoogle Scholar
  72. 72.
    Kromann CB, Ibler KS, Kristiansen VB, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94:553–7.PubMedGoogle Scholar
  73. 73.
    Von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14:389–92.PubMedGoogle Scholar
  74. 74.
    Melnik BC. Acneigenic stimuli converge in phosphoinositol-3 kinase/Akt/Foxo 1 signal transduction. J Clin Exp Dermatol Res. 2010;1:101.Google Scholar
  75. 75.
    Canoui-Poitrine F, Le Thaut A, Revuz JE, Vialette C, Gabison G, Poli F, Pouget F, Wolkenstein P, Bastuji-Garin S. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133:1506–11.PubMedGoogle Scholar
  76. 76.
    Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinology. 2010;2:9–16.Google Scholar
  77. 77.
    Rambhatla PV, Lim HW, Hamzavi I. A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol. 2012;148:439–46.PubMedGoogle Scholar
  78. 78.
    Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27:1101–8.PubMedGoogle Scholar
  79. 79.
    Jahns AC, Killasli H, Nosek D, Lundskog B, Lenngren A, Muratova Z, Emtestam L, Alexeyev OA. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS. 2014;122:804–9.PubMedGoogle Scholar
  80. 80.
    Blok JL, van Hattem S, Jonkmann MF, Horvath B. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol. 2013;168:243–52.PubMedGoogle Scholar
  81. 81.
    Matusiak L, Bieniek A, Szepietowski JC. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol. 2014;171:170–4.PubMedGoogle Scholar
  82. 82.
    Verdolini R, Simonacci F, Menon S, Pavlou P, Mannello B. Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child bearing age. G Ital Dermatol Venereol. 2014. [Epub ahead of print].Google Scholar
  83. 83.
    Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539–61.PubMedGoogle Scholar
  84. 84.
    Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213–27.PubMedGoogle Scholar
  85. 85.
    Kelly G, Sweeney CM, Tobin AM, Kirby B. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol. 2014;53:1186–96.PubMedGoogle Scholar
  86. 86.
    Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32:397–408.PubMedGoogle Scholar
  87. 87.
    Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205–17.PubMedGoogle Scholar
  88. 88.
    Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003;149:1046–9.PubMedGoogle Scholar
  89. 89.
    Fernandez-Vozmediano JM, Armario-Hita JC. Infliximab for the treatment of hidradenitis suppurativa. Dermatology. 2007;215:41–4.PubMedGoogle Scholar
  90. 90.
    Usmani N, Clayton TH, Everett S, Goodfield MDJ. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin Exp Dermatol. 2007;32:204–5.PubMedGoogle Scholar
  91. 91.
    Bahillo Monne C, Honorato Guerra S, Schoendorff Ortega C, Gargallo Quintero AB. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature. Dermatology. 2014;229:279–87.PubMedGoogle Scholar
  92. 92.
    Kerdel FA. Current and emerging nonsurgical treatment options for hidradenitis suppurativa. Semi Cutan Med Surg. 2014;33(3 suppl):S57–9.Google Scholar
  93. 93.
    Zhang J, Reeder VJ, Hamzavi IH. Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford hospital experience. Br J Dermatol. 2014;171:1600–2.PubMedGoogle Scholar
  94. 94.
    Moriarty B, Jiyad Z, Creamer D. Four-weekly infliximab in the treatment of severe hidradenitis suppurativa. Br J Dermatol. 2014;170:986–7.PubMedGoogle Scholar
  95. 95.
    Diamantova D, Lomickova I, Cetkovska P. Adalimumab treatment for hidradenitis suppurativa associated with Crohn’s disease. Acta Dermatovenerol Croat. 2014;22:291–3.PubMedGoogle Scholar
  96. 96.
    Fadel MA, Tawfik AA. New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study. Clin Exp Dermatol. 2014. doi: 10.1111/ced.12459. [Epub ahead of print].PubMedGoogle Scholar
  97. 97.
    Scheinfeld N. The use of photodynamic therapy to treat hidradenitis suppurativa a review and critical analysis. Dermatol Online J. 2015;21(1):Pii:13030/qt62j7j3c1.Google Scholar
  98. 98.
    Piccolo D, DiMarcantonio D, Crisman G, Cannarozzo G, Sannino M, Chiricozzi A, Chimenti S. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014:618206. doi: 10.1155/2014/618206. Epub 2014 Sep 3.CrossRefPubMedPubMedCentralGoogle Scholar
  99. 99.
    Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized controlled trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2009;35:1188–98.PubMedGoogle Scholar
  100. 100.
    Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36:208–13.Google Scholar
  101. 101.
    Blok JL, Spoo JR, Leeman FWJ, Jonkman MF, Horvath B. Skin-tissue-sparing excision with electrosurgical peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. J Eur Acad Dermatol Venereol. 2014.Google Scholar
  102. 102.
    Blok JL, Boersma M, Terra JB, Spoo JR,Leeman FW, van den Heuvel ER, Huizinga J, Jonkman MF, Horvath B. Surgery under general anesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol. 2015. doi: 10.1111/jdv.12952. [Epub ahead of print].PubMedGoogle Scholar
  103. 103.
    Alharbi Z, Kauczok J, Pallua N. A review of wide surgical excision of hidradenitis suppurativa. BMC Dermatol. 2012;12:9.PubMedPubMedCentralGoogle Scholar
  104. 104.
    Mizukami T, Fujiwara M, Ishikawa K, Aoyama S, Fukamizu H. Reconstruction for extensive groin hidradenitis suppurativa using combination of inferior abdominal flap and medial thigh-lift: a case report. Aesthetic Plast Surg. 2014;38:745–8.PubMedGoogle Scholar
  105. 105.
    Chen ML, Odom B, Santucci RA. Surgical management of genitoperineal hidradenitis suppurativa in men. Urology. 2014;83:1412–7.PubMedGoogle Scholar
  106. 106.
    Chen YE, Gerstle T, Verma K, treiser MD, Kimball AB, Orgill DP. Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconstr Surg. 2014;133:370e–7.PubMedGoogle Scholar
  107. 107.
    Yamashita Y, Hashimoto I, Matsuo S, Abe Y, Ishida S, Nakanishi H. Two-stage surgery for hidradenitis suppurativa: staged artificial dermis and skin grafting. Dermatol Surg. 2014;40:110–5.PubMedGoogle Scholar

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2016

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  1. 1.Colorectal Surgery, Department of Surgery, Uniformed Services University of the Health SciencesMadigan Army Medical CenterJoint Base Lewis-McChordUSA

Personalised recommendations